DE60006548D1 - High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks - Google Patents

High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks

Info

Publication number
DE60006548D1
DE60006548D1 DE60006548T DE60006548T DE60006548D1 DE 60006548 D1 DE60006548 D1 DE 60006548D1 DE 60006548 T DE60006548 T DE 60006548T DE 60006548 T DE60006548 T DE 60006548T DE 60006548 D1 DE60006548 D1 DE 60006548D1
Authority
DE
Germany
Prior art keywords
high density
density lipoprotein
organdy
combating
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006548T
Other languages
English (en)
Other versions
DE60006548T2 (de
Inventor
Gillian Cockerill
Norman Miller
Christoph Thiemermann
Michelle Macdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Behring AG
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Publication of DE60006548D1 publication Critical patent/DE60006548D1/de
Application granted granted Critical
Publication of DE60006548T2 publication Critical patent/DE60006548T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE60006548T 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks Expired - Lifetime DE60006548T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9919713.9A GB9919713D0 (en) 1999-08-19 1999-08-19 New medical use of high density lipoprotein
GB9919713 1999-08-19
PCT/GB2000/003182 WO2001013939A1 (en) 1999-08-19 2000-08-16 High density lipoprotein against organ dysfunction following haemorrhagic shock

Publications (2)

Publication Number Publication Date
DE60006548D1 true DE60006548D1 (de) 2003-12-18
DE60006548T2 DE60006548T2 (de) 2004-09-23

Family

ID=10859485

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60006548T Expired - Lifetime DE60006548T2 (de) 1999-08-19 2000-08-16 High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks
DE60039130T Expired - Lifetime DE60039130D1 (de) 1999-08-19 2000-08-16 High Density Lipoprotein zur Bekämpfung von Organdysfunktion infolge eines hämorrhagischen Schocks

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60039130T Expired - Lifetime DE60039130D1 (de) 1999-08-19 2000-08-16 High Density Lipoprotein zur Bekämpfung von Organdysfunktion infolge eines hämorrhagischen Schocks

Country Status (10)

Country Link
US (1) US6998388B1 (de)
EP (2) EP1369124B1 (de)
AT (2) ATE397454T1 (de)
AU (1) AU779578B2 (de)
CA (1) CA2376260C (de)
DE (2) DE60006548T2 (de)
DK (1) DK1210105T3 (de)
ES (2) ES2307869T3 (de)
GB (1) GB9919713D0 (de)
WO (1) WO2001013939A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035352A1 (de) 2000-07-20 2002-01-31 Zlb Bioplasma Ag Bern Verfahren zur Behandlung von instabiler Angina pectoris
EP1285662A1 (de) * 2001-08-20 2003-02-26 ZLB Bioplasma AG Rekonstituiertes High-Density -Lipoprotein zur Behandlung von Schlaganfällen und Ischämiezuständen
EP1425031B8 (de) * 2001-08-20 2008-09-03 CSL Behring AG High-density -lipoprotein zur behandlung von schlaganfällen und ischämiezuständen
EP1699527A1 (de) 2004-01-02 2006-09-13 Advanced Cardiovascular Systems, Inc. Mit lipoprotein hoher dichte beschichtete medizinprodukte
US7759315B2 (en) * 2005-03-09 2010-07-20 Csl Behring Ag Treatment of inflammatory conditions of the intestine
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
US7956035B2 (en) 2007-03-01 2011-06-07 Csl Limited Treatment of endothelial dysfunction in diabetic patients
WO2010057203A2 (en) 2008-11-17 2010-05-20 The Board Of Regents Of The University Of Texas System Hdl particles for delivery of nucleic acids
DK2767546T3 (en) 2011-02-07 2019-02-04 Cerenis Therapeutics Holding Sa Lipoprotein complexes and their preparation and uses
SG11201609084QA (en) 2014-05-02 2016-11-29 Cerenis Therapeutics Holding Sa Hdl therapy markers
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08198406A (ja) 1995-01-20 1996-08-06 Hitachi Ltd 自動倉庫設備
AU6773596A (en) 1995-08-17 1997-03-12 Protein Design Labs, Inc. Anti-selectin antibodies for prevention of multiple organ failure and acute organ damage
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
JPH1025248A (ja) * 1996-07-08 1998-01-27 Chemo Sero Therapeut Res Inst 抗血管リモデリング剤

Also Published As

Publication number Publication date
ES2209961T3 (es) 2004-07-01
ATE397454T1 (de) 2008-06-15
EP1210105A1 (de) 2002-06-05
WO2001013939A1 (en) 2001-03-01
AU779578B2 (en) 2005-01-27
AU6852500A (en) 2001-03-19
CA2376260A1 (en) 2001-03-01
CA2376260C (en) 2010-09-28
GB9919713D0 (en) 1999-10-20
DE60006548T2 (de) 2004-09-23
DK1210105T3 (da) 2004-03-22
EP1369124B1 (de) 2008-06-04
DE60039130D1 (de) 2008-07-17
ES2307869T3 (es) 2008-12-01
US6998388B1 (en) 2006-02-14
EP1369124A1 (de) 2003-12-10
ATE253931T1 (de) 2003-11-15
EP1210105B1 (de) 2003-11-12

Similar Documents

Publication Publication Date Title
BG106586A (en) Pyrazolopyramidines as therapeutic agents
DE60039729D1 (de) N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
EP1545483A4 (de) Nichtnukleosidische reverse-transkriptase-hemmer
PT907652E (pt) Compostos e processos imunossupressores
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
ATE245145T1 (de) Gut wasserlösliche triptolid-prodrugs
MY144318A (en) Methods of treating hiv infection.
ATE492525T1 (de) Phenyl-benzyl-ketone
SE9903759D0 (sv) Pharmaceutically active compounds
DE60006548D1 (de) High density lipoprotein zur bekämpfung von organdysfunktion infolge hämorrhagischem schocks
CY1110114T1 (el) Προσδετης αλφα-2-δελτα για την αγωγη των συμπτωματων του κατωτερου ουροποιητικου συστηματος
TR200202323T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavß6 antagonistleriyle tedavisi
DE60312736D1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DK0812831T3 (da) Benzimidazolderivater og deres anvendelse som antagonister for corticotropinfrigørende faktor
HK1048944A1 (en) Use of docetaxel in the manufacture of a medicament for use in the treatment of hepatocellar carcinoma.
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
NO20032597L (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
AR043016A2 (es) Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene
EP1539132A4 (de) Verwendung von 2,3 alkylcarbonyloxybenzosäuren, ihre derivate und analoga bei der behandlung von gewebe- und zellfunktionsschäden und verletzungen in säugetieren
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
ZA200209835B (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.
AR028458A1 (es) Un estuche de combinacion usado en el tratamiento del paludismo
DE60023321D1 (de) Zusammensetzung gegen Coccidiose

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ZLB BEHRING AG, BERN, CH

8328 Change in the person/name/address of the agent

Representative=s name: WEICKMANN & WEICKMANN, 81679 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: CSL BEHRING AG, BERN, CH